{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:40:00Z","timestamp":1791085200564,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116177","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:28:59Z","timestamp":1711560539000},"page":"116177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Osteostatin, a peptide for the future treatment of musculoskeletal diseases"],"prefix":"10.1016","volume":"223","author":[{"given":"Daniel","family":"Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arancha R.","family":"Gortazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0659-1545","authenticated-orcid":false,"given":"Sergio","family":"Portal-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116177_b0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2024.116177_b0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","article-title":"Osteoporosis","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2024.116177_b0015","first-page":"46","article-title":"An overview and management of osteoporosis, eur","volume":"4","author":"Sozen","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bcp.2024.116177_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101758","article-title":"Modifiable risk factors for bone health & fragility fractures","volume":"36","author":"Wilson-Barnes","year":"2022","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bcp.2024.116177_b0025","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116177_b0030","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jep.12800","article-title":"Osteoporotic fractures may impair life as much as the complications of diabetes","volume":"23","author":"Vok\u00f3","year":"2017","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.bcp.2024.116177_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1052592","article-title":"A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.bcp.2024.116177_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-022-00219-8","article-title":"Bone remodeling: an operational process ensuring survival and bone mechanical competence","volume":"10","author":"Bolamperti","year":"2022","journal-title":"Bone Res."},{"key":"10.1016\/j.bcp.2024.116177_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-022-08190-7","article-title":"Bone cells and their role in physiological remodeling","volume":"50","author":"Maciel","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2024.116177_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-023-01093-0","article-title":"Metabolic health and disease: a role of osteokines?","author":"Shimonty","year":"2023","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2024.116177_b0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00223-015-0050-1","article-title":"Parathyroid hormone-related protein analogs as osteoporosis therapies","volume":"98","author":"Esbrit","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2024.116177_b0060","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1210\/jc.2002-020773","article-title":"Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1\u201336) [hPTHrP-(1\u201336)] versus hPTH-(1\u201334) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers","volume":"88","author":"Horwitz","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116177_b0065","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.tem.2019.07.014","article-title":"Handling Parathormone receptor type 1 in skeletal diseases: realities and expectations of Abaloparatide","volume":"30","author":"Ardura","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2024.116177_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108383","article-title":"Pharmaceutical treatment of bone loss: from animal models and drug development to future treatment strategies","volume":"244","author":"Brent","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116177_b0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tem.2017.06.003","article-title":"Unexpected bone formation produced by RANKL blockade","volume":"28","author":"Portal-N\u00fa\u00f1ez","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bcp.2024.116177_b0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of Abaloparatide vs placebo on new vertebral Fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bcp.2024.116177_b0085","doi-asserted-by":"crossref","unstructured":"M.R. McClung, M.L. O\u2019Donoghue, S.E. Papapoulos, H. Bone, B.L. Langdahl, K.G. Saag, I.R. Reid, D.P. Kiel, I. Cavallari, M.P. Bonaca, S.D. Wiviott, T. de Villiers, X. Ling, K. Lippuner, T. Nakamura, J.Y. Reginster, J.A. Rodriguez-Portales, C. Roux, J. Zanchetta, C.A.F. Zerbini, J.G. Park, K.A. Im, A. Cange, L.T. Grip, N. Heyden, C. DaSilva, D. Cohn, R. Massaad, B.B. Scott, N. Verbruggen, D. Gurner, D.L. Miller, M.L. Blair, A.B. Polis, S.A. Stoch, A. Santora, A. Lombardi, A.T. Leung, K.D. Kaufman, M.S. Sabatine, C.A. Mautal\u00e9n, Z. Man, J.R. Zanchetta, C.H. Magaril, P. Sambrook, P. Geusens, S. Goemaere, B.H. Albergaria, C.A. de F. Zerbini, M.L. Castro, L.H. Gregorio, R. Stoilov, A.M.I. Borissova, K.H. Hristozov, N.L. Temelkova, I.K. Daskalova, S.I. Kuzmanova, D. Yaneva-Bichovska, A.Z. Batalov, P. Riedemann, J.A. Rodriguez Portales, H. Tang, hanmin Zhu, Z. Zhang, A. Chao, Y. Hu, Z. Liu, J. Lu, M. Qiu, X. Gao, S. Zhang, L. Xu, W. Xia, E. Liao, W. Yang, W. Wu, K. Dai, R. Hu, J.J. Jaller, F. Cabal, J.F. Molina, C.A. Cure Cure, H. Yupanqui-Lozno, P. Chalem, J. Londono, M. Abello, E.D. Tobias, W. Otero, T. Nikolic, B. Miskic, J. Stepan, V. Vyskocil, L. Novosad, J. Slesinger, P. Novosad, E. Vlckova, L. Bortlik, E. Dokoupilova, T. Hala, J.E.B. Jensen, K.T. Brixen, P. Schwarz, P.C. Eskildsen, P.A. Eiken, A.P. Hermann, J. Gram, M.B. Schou, P. Alexandersen, B. Nedergaard, D.M. Mej\u00eda, L. Estrella De Henriquez, N. P\u00e1ez, C. Velazco, I. Valter, K.L. Vahula, I. Kull, K. Maasalu, R. Chapurlat, P. Fardellone, C.L. Benhamou, G. Weryha, V. Herkt, R. Martz, R. Nischik, W. Spieler, C. Contzen, D. Felsenberg, I. Frieling, E. Frahm, H. Briones, B. Sandoval, P. Barrios, A. Garc\u00eda, C. Avenda\u00f1o, M. Gonz\u00e1lez, J. Guerra, M. Tuna, O.M. D\u00edaz, E. Samayoa, E. L\u00f3pez, J.R. Barrera, M. Palencia, M. Cifuentes, G. Alvarado, M. L\u00f3pez, N. Chavez, F. Haase, R. Rivera, C. Gonz\u00e1lez, K. Tan, P.C. Leung, S. Mandalam, S.U. Pitale, G. Bantwal, A.C. Ammini, S.S.A. Shaikh, P.K. Kanakatte Mylariah, M. Dharmalingam, S. Mukhopadhyay, A. Jain, P. Singh, N. Shetty, S.S. Sathyanarayana, N. Shah, M.D. Chadha, R. Bhandankar, K. Velayutham, S. Marwah, M. John, R.K. Sahay, S. Adami, R. Nuti, G. Bianchi, M.L. Brandi, S. Minisola, C.E. Fiore, A. Rubinacci, H. Miyajima, H. Yamane, Y. Nakatani, S. Okamoto, K. Kuroda, M. Fujimori, A. Itabashi, K. Katayama, S. Nakajo, Y. Somekawa, Y. Ohsawa, W. Tajima, K. Mizuno, S. Mori, T. Kanabuchi, H. Hashizume, N. Oka, K. Hamada, M. Yamaguchi, F. Hirahara, M. Atobe, Y. Ohtake, S. Ichikawa, T. Onishi, K. Matsumoto, T. Nakamura, E. Shirasawa, K. Katayama, M. Takahashi, T. Oguma, H. Matsui, Y. Katoh, K. Shigenobu, T. Onishi, M. Shibukawa, S. Ikeda, K. Osaka, R. Kanda, Y. Inobe, M. Shigenobu, M. Hasegawa, T. Yamaji, Y. Miyazaki, T. Ito, E. Nakamura, S. Nagai, S.K. Lim, Y.S. Chung, C.S. Shin, Y.K. Min, G.S. Kim, H.K. Yoon, M. Il Kang, K.H. Yang, H.M. Park, I.J. Kim, D.J. Chung, H.Y. Chung, S. Jaundzeikare, D. Andersone, A. Medne, Y. Yaghi, V. Alekna, V. Kasiulevicius, I. Purtokaite - Labutiniene, A. Krasauskiene, J. Varanaviciene, V. Basijokiene, A. Abraitiene, L. Radzeviciene, J. Walliser, P.A. Garc\u00eda Hern\u00e1ndez, M.F. Araujo, H.E. Avila Armengol, P. De la Pe\u00f1a, J. Tamayo, B. Zazueta, F. Cons, N.L. Gilchrist, I.R. Reid, R. Leikis, P. Jones, J.G.P. Singh, J.I. Halse, U. Syversen, H.O. H\u00f8ivik, E.S. \u00d8fjord, H.C. Gulseth, S. Elle, P.D. Norheim, A.A. Calvo Quiroz, P.A. Cesar Augusto, M.G. Le\u00f3n Portocarrero, L.F. Vidal Neira, J. Chavez, B. Garro Barrera, R. Kuroiwa Sampei, B. V. Luis Fernando, R. Oquelis Cabredo, S. Castillo, A.M.G. Morales, P.P. Tan, L.A.C. Leagogo, E.H. Wang, J.T. Li-Yu, A.Z. Sawicki, B. Stasiuk, G. Kania, R. Lorenc, A. Sidorowicz-Bialynicka, L. Szczepanski, E. Franek, R. Filip, J. Sekula, T. Blicharski, P. Leszczynski, E. Sewerynek, T. Miazgowski, A. Milewicz, M. Dabrowska, J. Romaszko, W. Pluskiewicz, L. Wojnowski, C. Codreanu, H. Bolosiu, R. Ionescu, I. Zosin, L. Macovei, M. Bojinca, F. Radulescu, S. Pop, A. Sarbu, L.I. Benevolenskaya, E.L. Nasonov, L.Y. Rozhinskaya, R.G. Oganov, S.S. Rodionova, E.V. Shlyakhto, V. Trofimov, E.G. Zotkin, I.E. Zazerskaya, E.N. Grineva, O. Ershova, O. Lesnyak, O.D. Ostroumova, S.B. Malichenko, E.G. Pikhlak, V.G. Pilyaev, T. Raskina, E. V. Zonova, V.S. Shirinsky, A.N. Dimic, G. Cobeljic, S. Vujovic, G.C. Ellis, S. Lipschitz, T.J. De Villiers, A.J. De Weerd, T. Vally, Y. Trinder, J.L. Coetsee, C.P. Davis, S. Nayiager, F.S. Hough, L.F. Oelofse, E. van der Walt, J.J. Lombaard, S. Blignaut, U. Govind, L.F. Fouche, D.S. Kruger, J.P. Dalmeyer, M.M. Ferreira, A. Escudero-Contreras, M. Mu\u00f1oz Torres, F. Hawkins Carranza, J.L. Perez Castrillon, J.A. Garc\u00eda Meijide, E. Jodar Gimeno, S. Palacios Gil-Antu\u00f1ana, L. de Teresa Parreno, E. Mart\u00edn Mola, C. Alvarez Sanchez, K.S. Tsai, S. Te Tu, J.F. Chen, O.K.S. Lee, W.W. Hsu, N.V. Grygorieva, V.V. Povoroznyuk, M.O. Korzh, O.L. Loskutov, A.B. Chukov, R. Sarmiento, H. Thomas, H. Donnachie, I. Pavel-Knox, H. Shaw, H. Hassanin, E.E.A. Abdulhakim, N. Savani, G.A. Bachmann, E. Barrett-Connor, N.C. Binkley, H.G. Bone, D.M. Brandon, D.D. Checketts, N.J. Fraser, N.B. Watts, S.A. Geller, J.S. Gimbel, M.W. Greenwald, P.A. Holt, C.C. Johnston, C. Fang, D.J. Klashman, E.M. Lewiecki, M.B. Lowenstein, M.R. McClung, S.M. Nattrass, A. Odio, J. Levengood, J. Romaguera, M.B. Sebai, B. Snyder, M.E. Kutner, D. Streja, E.P. Schwartz, M.G. Christiansen, Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study, Lancet Diabetes Endocrinol 7 (2019) 899\u2013911. https:\/\/doi.org\/10.1016\/S2213-8587(19)30346-8.","DOI":"10.1016\/S2213-8587(19)30346-8"},{"key":"10.1016\/j.bcp.2024.116177_b0090","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116177_b0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.167.3916.279","article-title":"Silicon: a possible factor in bone calcification","volume":"167","author":"Carlisle","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116177_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ma12111824","article-title":"Scaffolding strategies for tissue engineering and regenerative medicine applications","volume":"12","author":"Pina","year":"2019","journal-title":"Materials (basel)"},{"key":"10.1016\/j.bcp.2024.116177_b0105","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1073\/pnas.1508520112","article-title":"Regenerative medicine: current therapies and future directions","volume":"112","author":"Mao","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2024.116177_b0110","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116177_b0115","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1073\/pnas.84.14.5048","article-title":"Parathyroid hormone-related protein purified from a human lung cancer cell line","volume":"84","author":"Moseley","year":"1987","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2024.116177_b0120","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1021\/bi00189a054","article-title":"Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing","volume":"33","author":"Yang","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2024.116177_b0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"J\u00fcppner","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bcp.2024.116177_b0130","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/endo.142.2.7944","article-title":"Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine","volume":"142","author":"Nguyen","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0135","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1359\/jbmr.1999.14.9.1493","article-title":"The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation","volume":"14","author":"Aarts","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116177_b0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-4644(19980801)70:2<193::AID-JCB5>3.0.CO;2-J","article-title":"The nucleus: a Target site for Parathyroid hormone-related peptide (PTHrP) action","volume":"70","author":"Nguyen","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116177_b0145","doi-asserted-by":"crossref","unstructured":"R.E. Toribio, H.A. Brown, C.M. Novince, B. Marlow, K. Hernon, L.G. Lanigan, B.E.H. III, J.L. Werbeck, S.T. Shu, G. Lorch, M. Carlton, J. Foley, P. Boyaka, L.K. McCauley, T.J. Rosol, The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice, The FASEB Journal 24 (2010) 1947\u20131957. https:\/\/doi.org\/10.1096\/fj.09-147033.","DOI":"10.1096\/fj.09-147033"},{"key":"10.1016\/j.bcp.2024.116177_b0150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/me.2013-1225","article-title":"Functional roles of the nuclear localization signal of parathyroid hormone-related protein (PTHrP) in osteoblastic cells","volume":"28","author":"Garc\u00eda-Mart\u00edn","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2024.116177_b0155","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/MCB.15.8.4064","article-title":"Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death","volume":"15","author":"Henderson","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116177_b0160","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1210\/endo.136.4.7895691","article-title":"Involvement of cell cycle and mitogen-activated pathways in induction of parathyroid hormone-related protein gene expression in rat aortic smooth muscle cells","volume":"136","author":"Okano","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0165","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-4652(199712)173:3<433::AID-JCP16>3.0.CO;2-C","article-title":"PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle","volume":"173","author":"Lam","year":"1997","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bone.2013.02.016","article-title":"Modeling distinct osteosarcoma subtypes in vivo using cre:lox and lineage-restricted transgenic shRNA","volume":"55","author":"Mutsaers","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bcp.2024.116177_b0175","first-page":"1110","article-title":"Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormone-related peptide in humoral hypercalcemia of malignancy","volume":"75","author":"Burtis","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2024.116177_b0180","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer","volume":"322","author":"Burtis","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116177_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.1041550102","article-title":"Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139]","volume":"155","author":"Fenton","year":"1993","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0190","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/endo-129-4-1762","article-title":"A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts","author":"Fenton","year":"1991","journal-title":"Endocrinology 129"},{"key":"10.1016\/j.bcp.2024.116177_b0195","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1210\/endo-129-6-3424","article-title":"A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]","volume":"129","author":"Fenton","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0200","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1210\/endo.137.5.8612492","article-title":"Elimination of the carboxy-terminal sequences of parathyroid hormone-related protein 1\u2013173 increases production and secretion of the truncated forms","volume":"137","author":"Ditmer","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0205","first-page":"64","article-title":"Structure study of osteostatin PTHrP[Thr107](107\u2013139)","volume":"1432","author":"Cuthbertson","year":"1999","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2024.116177_b0210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jbmr.5650080414","article-title":"Protein kinase C-activating domains of parathyroid hormone-related protein","volume":"8","author":"Gagnon","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116177_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199601)166:1<1::AID-JCP1>3.0.CO;2-T","article-title":"C-terminal fragment of Parathyroid hormone-related protein, PTHrP-(1 07\u20131 1 1), stimulates membrane-associated protein kinase C activity and modulates the proliferation of human and murine skin keratinocytes","volume":"166","author":"Whitfield","year":"1996","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0220","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/jcb.24482","article-title":"Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function","volume":"114","author":"Garc\u00eda-Mart\u00edn","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116177_b0225","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1210\/endo.142.7.8276","article-title":"C-terminal parathyroid hormone-related protein (PTHrP) (107\u2013139) stimulates intracellular Ca(2+) through a receptor different from the type 1 PTH\/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells","volume":"142","author":"Val\u00edn","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0230","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jcp.1041580317","article-title":"C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107\u2013111) and (107\u2013139), and the N-terminal PTHrP-(1\u201340) fragment stimulate membrane-associated protein kinase C activity in rat spleen lymphocytes","volume":"158","author":"Whitfield","year":"1994","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0235","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jcp.21547","article-title":"Parathyroid hormone-related protein (107\u2013139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2","volume":"217","author":"Alonso","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00223-006-0099-y","article-title":"Transient exposure to PTHrP (107\u2013139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro","volume":"79","author":"De Gort\u00e1zar","year":"2006","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2024.116177_b0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2022.02.085","article-title":"Osteostatin improves the osteogenic differentiation of mesenchymal stem cells and enhances angiogenesis through HIF-1\u03b1 under hypoxia conditions in vitro","volume":"606","author":"Wu","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116177_b0250","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1210\/endo.142.9.8388","article-title":"The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells","volume":"142","author":"De Miguel","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0255","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jbmr.5650090411","article-title":"Carboxyl-terminal parathyroid hormone-related protein inhibits bone resorption by isolated chicken osteoclasts","volume":"9","author":"Fenton","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116177_b0260","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1210\/endo.136.3.7867592","article-title":"Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation","volume":"136","author":"Kaji","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116177_b0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00298996","article-title":"Lack of significant effect of carboxyl-terminal parathyroid hormone-related peptide fragments on isolated rat and chick osteoclasts","volume":"57","author":"Murrills","year":"1995","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bcp.2024.116177_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158551","article-title":"Osteostatin inhibits M-CSF+RANKL-induced human osteoclast differentiation by modulating NFATc1","volume":"23","author":"Ib\u00e1\u00f1ez","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116177_b0275","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/ten.tea.2009.0355","article-title":"Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment","volume":"16","author":"De Castro","year":"2010","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.bcp.2024.116177_b0280","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcp.22902","article-title":"Comparison of the skeletal effects induced by daily administration of PTHrP (1\u201336) and PTHrP (107\u2013139) to ovariectomized mice","volume":"227","author":"de Castro","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2024.116177_b0285","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1476-5381.2010.01155.x","article-title":"The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia","volume":"162","author":"Lozano","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116177_b0290","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/jcb.24535","article-title":"Inhibition of the canonical wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells","volume":"114","author":"L\u00f5pez-Herrad\u00f5n","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116177_b0295","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.febslet.2010.05.047","article-title":"Alterations of the wnt\/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice","volume":"584","author":"Portal-N\u00fa\u00f1ez","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2024.116177_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087536","article-title":"Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice","volume":"9","author":"Rodr\u00edguez-de La Rosa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116177_b0305","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jbmr.3007","article-title":"PTHrP-derived peptides restore bone mass and strength in diabetic mice: additive effect of mechanical loading","volume":"32","author":"Maycas","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2024.116177_b0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116177_b0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1302\/2046-3758.71.BJR-2016-0242.R2","article-title":"Parathyroid hormone-related protein exhibits antioxidant features in osteoblastic cells through its N-terminal and osteostatin domains","volume":"7","author":"Portal-N\u00fa\u00f1ez","year":"2018","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.bcp.2024.116177_b0320","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/jbm.a.35742","article-title":"Local delivery of parathyroid hormone-related protein-derived peptides coated onto a hydroxyapatite-based implant enhances bone regeneration in old and diabetic rats","volume":"104","author":"Ardura","year":"2016","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.bcp.2024.116177_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163845","article-title":"Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis","volume":"20","author":"N\u00e1cher-Juan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116177_b0330","first-page":"624","article-title":"Anti-senescence and anti-inflammatory effects of the C-terminal moiety of PTHrP peptides in OA osteoblasts","volume":"72","author":"Platas","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bcp.2024.116177_b0335","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3390\/ijms25052752","article-title":"Osteostatin mitigates gouty arthritis through the inhibition of Caspase-1 activation and upregulation of Nrf2 expression","volume":"25","author":"Catal\u00e1n","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116177_b0340","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1006\/jmcc.1997.0520","article-title":"Effects of PTH-rP(107\u2013111) and PTH-rP(7\u201334) on adult cardiomyocytes","volume":"29","author":"Schl\u00fcter","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2024.116177_b0345","first-page":"17","article-title":"Cardiac effects of osteostatin in mice","volume":"63","author":"Meyer","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116177_b0350","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.joen.2017.08.016","article-title":"Odontogenic potential of Parathyroid hormone-related protein (107\u2013111) alone or in combination with mineral trioxide aggregate in human dental pulp cells","volume":"43","author":"Han","year":"2017","journal-title":"J. Endod."},{"key":"10.1016\/j.bcp.2024.116177_b0355","doi-asserted-by":"crossref","DOI":"10.5395\/rde.2021.46.e17","article-title":"Hard tissue formation after direct pulp capping with osteostatin and MTA in vivo","volume":"46","author":"Yoon","year":"2021","journal-title":"Restor Dent Endod"},{"key":"10.1016\/j.bcp.2024.116177_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010202","article-title":"Mesoporous bioglasses enriched with bioactive agents for bone repair, with a special highlight of Mar\u00eda vallet-reg\u00ed\u2019s contribution","volume":"14","author":"Salinas","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2024.116177_b0365","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.actbio.2009.08.033","article-title":"Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation","volume":"6","author":"Lozano","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0370","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.actbio.2012.03.014","article-title":"Osteostatin-loaded onto mesoporous ceramics improves the early phase of bone regeneration in a rabbit osteopenia model","volume":"8","author":"Lozano","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0375","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1016\/j.actbio.2011.06.004","article-title":"Comparison of the osteoblastic activity conferred on si-doped hydroxyapatite scaffolds by different osteostatin coatings","volume":"7","author":"Manzano","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0380","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.actbio.2012.04.002","article-title":"Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in si-doped hydroxyapatite in osteoblastic cells","volume":"8","author":"Lozano","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0385","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1016\/j.actbio.2014.03.025","article-title":"Parathyroid hormone-related protein (107\u2013111) improves the bone regeneration potential of gelatin-glutaraldehyde biopolymer-coated hydroxyapatite","volume":"10","author":"Lozano","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.actbio.2019.03.033","article-title":"Osteostatin potentiates the bioactivity of mesoporous glass scaffolds containing Zn2+ ions in human mesenchymal stem cells","volume":"89","author":"Heras","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bcp.2024.116177_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/nano8080592","article-title":"Osteogenic effect of ZnO-mesoporous glasses loaded with osteostatin","volume":"8","author":"P\u00e9rez","year":"2018","journal-title":"Nanomaterials (basel)"},{"key":"10.1016\/j.bcp.2024.116177_b0400","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/adhm.201500439","article-title":"Functionalization of a collagen-hydroxyapatite scaffold with osteostatin to facilitate enhanced bone regeneration","volume":"4","author":"Quinlan","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bcp.2024.116177_b0405","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.9b00241","article-title":"Nanoparticles to knockdown osteoporosis-related gene and Promote osteogenic Marker expression for osteoporosis treatment","volume":"13","author":"Mora-Raimundo","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.bcp.2024.116177_b0410","article-title":"Osteoporosis remission and new bone formation with mesoporous silica Nanoparticles","volume":"8","author":"Mora-Raimundo","year":"2021","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.bcp.2024.116177_b0415","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1039\/D1CS00659B","article-title":"Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?","volume":"51","author":"Vallet-Reg\u00ed","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bcp.2024.116177_b0420","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1089\/ten.tea.2014.0476","article-title":"Osteostatin-coated porous titanium can improve early bone regeneration of cortical bone defects in rats","volume":"21","author":"Van Der Stok","year":"2015","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.bcp.2024.116177_b0425","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1016\/j.biomaterials.2010.07.103","article-title":"The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model","volume":"31","author":"Trejo","year":"2010","journal-title":"Biomaterials"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:24:07Z","timestamp":1728951847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":85,"alternative-id":["S0006295224001606"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116177","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteostatin, a peptide for the future treatment of musculoskeletal diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Universidad San Pablo CEU. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116177"}}